Genetic Insights into the Gut-Lung Axis: Mendelian Randomization Analysis on Gut Microbiota, Lung Function, and COPD

References

• Christenson SA, Smith BM, Bafadhel M, Putcha N. Chronic obstructive pulmonary disease. Lancet. 2022;399(10342):2227–2242. doi:10.1016/S0140-6736(22)00470-6
   PubMed Web of Science ®Google Scholar
• Stolz D, Mkorombindo T, Schumann DM, et al. Towards the elimination of chronic obstructive pulmonary disease: a Lancet Commission. Lancet. 2022;400:921–972.
   PubMed Web of Science ®Google Scholar
• Ruan W, Engevik MA, Spinler JK, Versalovic J. Healthy human gastrointestinal microbiome: composition and function after a decade of exploration. Dig Dis Sci. 2020;65(3):695–705. doi:10.1007/s10620-020-06118-4
   PubMed Web of Science ®Google Scholar
• Budden KF, Gellatly SL, Wood DLA, et al. Emerging pathogenic links between microbiota and the gut–lung axis. Nat Rev Microbiol. 2017;15(1):55–63. doi:10.1038/nrmicro.2016.142
   PubMed Web of Science ®Google Scholar
• Wypych TP, Wickramasinghe LC, Marsland BJ. The influence of the microbiome on respiratory health. Nat Immunol. 2019;20(10):1279–1290. doi:10.1038/s41590-019-0451-9
   PubMed Web of Science ®Google Scholar
• Lai H-C, Lin T-L, Chen T-W, et al. Gut microbiota modulates COPD pathogenesis: role of anti-inflammatory Parabacteroides goldsteinii lipopolysaccharide. Gut. 2022;71(2):309–321. doi:10.1136/gutjnl-2020-322599
   PubMed Web of Science ®Google Scholar
• Li N, Dai Z, Wang Z, et al. Gut microbiota dysbiosis contributes to the development of chronic obstructive pulmonary disease. Respir Res. 2021;22(1):274. doi:10.1186/s12931-021-01872-z
   PubMed Web of Science ®Google Scholar
• Chiu Y-C, Lee S-W, Liu C-W, Lan T-Y, Ls-h W. Relationship between gut microbiota and lung function decline in patients with chronic obstructive pulmonary disease: a 1-year follow-up study. Respir Res. 2022;23(1):10. doi:10.1186/s12931-022-01928-8
   Web of Science ®Google Scholar
• Chiu Y-C, Lee S-W, Liu C-W, et al. Comprehensive profiling of the gut microbiota in patients with chronic obstructive pulmonary disease of varying severity. PLoS One. 2021;16(4):e0249944. doi:10.1371/journal.pone.0249944
   PubMed Web of Science ®Google Scholar
• Wu Y, Luo Z, Liu C. Variations in fecal microbial profiles of acute exacerbations and stable chronic obstructive pulmonary disease. Life Sci. 2021;265:118738. doi:10.1016/j.lfs.2020.118738
   Web of Science ®Google Scholar
• Combrink L, Humphreys IR, Washburn Q, et al. Best practice for wildlife gut microbiome research: a comprehensive review of methodology for 16S rRNA gene investigations. Front Microbiol. 2023;14:1092216. doi:10.3389/fmicb.2023.1092216
   Web of Science ®Google Scholar
• Pragman AA, Kim HB, Reilly CS, Wendt C, Isaacson RE, Doern GV. Chronic obstructive pulmonary disease lung microbiota diversity may be mediated by age or inhaled corticosteroid use. J Clin Microbiol. 2015;53(3):1050. doi:10.1128/JCM.03320-14
   Web of Science ®Google Scholar
• Davies NM, Holmes MV, Davey Smith G. Reading Mendelian randomisation studies: a guide, glossary, and checklist for clinicians. BMJ. 2018;362:k601. doi:10.1136/bmj.k601
   PubMed Web of Science ®Google Scholar
• Song J, Wu Y, Yin X, Ma H, Zhang J. The causal links between gut microbiota and COVID-19: a Mendelian randomization study. J Med Virol. 2023;95(5):e28784. doi:10.1002/jmv.28784
   Web of Science ®Google Scholar
• Wei Y, Lu X, Liu C. Gut microbiota and chronic obstructive pulmonary disease: a Mendelian randomization study. Front Microbiol. 2023;14:1196751. doi:10.3389/fmicb.2023.1196751
   Web of Science ®Google Scholar
• Jin Q, Ren F, Dai D, Sun N, Qian Y, Song P. The causality between intestinal flora and allergic diseases: insights from a bi-directional two-sample Mendelian randomization analysis. Front Immunol. 2023;14:1121273. doi:10.3389/fimmu.2023.1121273
   PubMed Web of Science ®Google Scholar
• Bowden J, Holmes MV. Meta-analysis and Mendelian randomization: a review. Res Synth Methods. 2019;10(4):486–496. doi:10.1002/jrsm.1346
   PubMed Web of Science ®Google Scholar
• Bowden J, Davey Smith G, Burgess S. Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression. Int J Epidemiol. 2015;44(2):512–525. doi:10.1093/ije/dyv080
   PubMed Web of Science ®Google Scholar
• Verbanck M, Chen C-Y, Neale B, Do R. Detection of widespread horizontal pleiotropy in causal relationships inferred from Mendelian randomization between complex traits and diseases. Nat Genet. 2018;50(5):693–698. doi:10.1038/s41588-018-0099-7
   PubMed Web of Science ®Google Scholar
• Deng L, Shi Y, Liu P, et al. GeGen QinLian decoction alleviate influenza virus infectious pneumonia through intestinal flora. Biomed Pharmacother. 2021;141:111896. doi:10.1016/j.biopha.2021.111896
   PubMed Web of Science ®Google Scholar
• Zheng H-C, Liu Z-R, Li Y-L, et al. Allium tuberosum alleviates pulmonary inflammation by inhibiting activation of innate lymphoid cells and modulating intestinal microbiota in asthmatic mice. J Integr Med. 2021;19(2):158–166. doi:10.1016/j.joim.2020.11.003
   Google Scholar
• B-h G, Choi J-P, Park T, et al. Adult asthma with symptomatic eosinophilic inflammation is accompanied by alteration in gut microbiome. Allergy. 2023;78(7):1909–1921. doi:10.1111/all.15691
   Web of Science ®Google Scholar
• Buendía E, Zakzuk J, San-Juan-Vergara H, Zurek E, Ajami NJ, Caraballo L. Gut microbiota components are associated with fixed airway obstruction in asthmatic patients living in the tropics. Sci Rep. 2018;8(1):9582. doi:10.1038/s41598-018-27964-3
   PubMedGoogle Scholar
• He J, Zhang P, Shen L, et al. Short-chain fatty acids and their association with signalling pathways in inflammation, glucose and lipid metabolism. Int J Mol Sci. 2020;21(17):6356. doi:10.3390/ijms21176356
   PubMed Web of Science ®Google Scholar
• Ney L-M, Wipplinger M, Grossmann M, Engert N, Wegner VD, Mosig AS. Short chain fatty acids: key regulators of the local and systemic immune response in inflammatory diseases and infections. Open Biol. 2023;13(3):230014. doi:10.1098/rsob.230014
   Web of Science ®Google Scholar
• Jang YO, Kim O-H, Kim SJ, et al. High-fiber diets attenuate emphysema development via modulation of gut microbiota and metabolism. Sci Rep. 2021;11(1):7008. doi:10.1038/s41598-021-86404-x
   PubMed Web of Science ®Google Scholar
• Jang YO, Lee SH, Choi JJ, et al. Fecal microbial transplantation and a high fiber diet attenuates emphysema development by suppressing inflammation and apoptosis. Exp Mol Med. 2020;52(7):1128–1139. doi:10.1038/s12276-020-0469-y
   PubMed Web of Science ®Google Scholar
• Lee SH, Kim J, Kim NH, et al. Gut microbiota composition and metabolite profiling in smokers: a comparative study between emphysema and asymptomatic individuals with therapeutic implications. Thorax. 2023;78(11):1080–1089. doi:10.1136/thorax-2021-217923
   Web of Science ®Google Scholar
• Szmidt MK, Kaluza J, Harris HR, Linden A, Wolk A. Long-term dietary fiber intake and risk of chronic obstructive pulmonary disease: a prospective cohort study of women. Eur J Nutr. 2020;59(5):1869–1879. doi:10.1007/s00394-019-02038-w
   PubMed Web of Science ®Google Scholar
• Minamoto Y, Otoni CC, Steelman SM, et al. Alteration of the fecal microbiota and serum metabolite profiles in dogs with idiopathic inflammatory bowel disease. Gut Microbes. 2015;6(1):33–47. doi:10.1080/19490976.2014.997612
   PubMed Web of Science ®Google Scholar
• Gevers D, Kugathasan S, Denson LA, et al. The treatment-naive microbiome in new-onset Crohn’s disease. Cell Host Microbe. 2014;15(3):382–392. doi:10.1016/j.chom.2014.02.005
   PubMed Web of Science ®Google Scholar
• Rutten EPA, Lenaerts K, Buurman WA, Wouters EFM. Disturbed Intestinal Integrity in Patients With COPD. Chest. 2014;145(2):245–252. doi:10.1378/chest.13-0584
   PubMed Web of Science ®Google Scholar
• Kirschner SK, Deutz NEP, Jonker R, et al. Intestinal function is impaired in patients with Chronic Obstructive Pulmonary Disease. Clin Nutr. 2021;40(4):2270–2277. doi:10.1016/j.clnu.2020.10.010
   Web of Science ®Google Scholar
• Ekbom A, Brandt L, Granath F, Löfdahl C-G, Egesten A. Increased risk of both ulcerative colitis and Crohn’s disease in a population suffering from COPD. Lung. 2008;186(3):167–172. doi:10.1007/s00408-008-9080-z
   Web of Science ®Google Scholar
• Lee J, Im JP, Han K, et al. Risk of inflammatory bowel disease in patients with chronic obstructive pulmonary disease: a nationwide, population-based study. World J Gastroenterol. 2019;25(42):6354–6364. doi:10.3748/wjg.v25.i42.6354
   Web of Science ®Google Scholar
• Du Y, Li X, An Y, Song Y, Lu Y. Association of gut microbiota with sort-chain fatty acids and inflammatory cytokines in diabetic patients with cognitive impairment: a cross-sectional, non-controlled study. Front Nutr. 2022;9:930626. doi:10.3389/fnut.2022.930626
   Web of Science ®Google Scholar
• Pujo J, Petitfils C, Le Faouder P, et al. Bacteria-derived long chain fatty acid exhibits anti-inflammatory properties in colitis. Gut. 2021;70(6):1088–1097. doi:10.1136/gutjnl-2020-321173
   PubMed Web of Science ®Google Scholar